Annexon Biosciences
CA - BrisbaneBiotechnology
Focus: Annexon Biosciences is a public biotechnology company focused on complement-mediated therapies for neurodegenerative and autoimmune disorders. The company operates at clinical-stage maturity with two Phase 3 programs in advanced development.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
9+5 this month
Growing — net +5 jobs in 30d
6 jobs added vs 1 removed. Steady team buildout.
Should You Work at Annexon Biosciences?
AI assessmentBest suited for clinical development professionals seeking mid-stage biotech exposure with meaningful Phase 3 catalysts, but limited hiring and pre-commercialization stage reduce career acceleration opportunities.
Why Work Here
- Two Phase 3 programs (ANX005 in Guillain-Barré Syndrome and ANX007 in Geographic Atrophy) positioned for near-term clinical catalysts and potential commercial launches
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data F
Age Related Macular Degeneration (AMD)Clinical Trials (1)
NCT07424235Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort
N/AHelp build intelligence for Annexon Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.